Inherited human RelB deficiency impairs innate and adaptive immunity to infection.
NF-κB pathway
RelB deficiency
autoantibodies
immunodeficiency
type I IFNs
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
4
9
2024
Statut:
ppublish
Résumé
We report two unrelated adults with homozygous (P1) or compound heterozygous (P2) private loss-of-function variants of V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (
Identifiants
pubmed: 39231201
doi: 10.1073/pnas.2321794121
doi:
Substances chimiques
Transcription Factor RelB
147337-75-5
RELB protein, human
0
NF-kappa B p52 Subunit
0
NFKB2 protein, human
0
Interferon Type I
0
Types de publication
Journal Article
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2321794121Subventions
Organisme : HHMI (HHMI)
ID : N/A
Organisme : HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
ID : R01AI127564
Organisme : HHS | NIH | National Center for Advancing Translational Sciences (NCATS)
ID : UL1TR001866
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-10-IAHU-01
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-10-LABX-62-IBEID
Organisme : Fondation pour la Recherche Médicale (FRM)
ID : EQU201903007798
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-20-CO11-0001
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-18-CE93-0008
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-22-CE15-0046
Organisme : Square Foundation
ID : N/A
Organisme : Grandir - Fonds de solidarité pour l'enfance
ID : N/A
Organisme : Fondation du Souffle (FdS)
ID : N/A
Organisme : William E. Ford, General Atlantic's Chairman and Chief Executive Officer, Gabriel Caillaux, General Atlantic's Co-President, Managing Director and Head of business in EMEA, General Atlantic Foundation
ID : N/A
Organisme : Imagine Institute
ID : N/A
Organisme : Institut National de la Santé et de la Recherche Médicale (Inserm)
ID : N/A
Organisme : Paris Cite University
ID : N/A
Organisme : Rockefeller University (The Rockefeller Institute)
ID : N/A
Organisme : Agence Nationale de la Recherche (ANR)
ID : ANR-21-RHUS-08-COVIFERON
Organisme : EC | HORIZON EUROPE Framework Programme (Horizon Europe)
ID : 01057100 (UNDINE)
Organisme : Bettencourt-Schueller Foundation
ID : N/A
Organisme : European Society for Immunodeficiencies (ESID)
ID : N/A
Organisme : FULBRIGHT | Fulbright U.S. Scholar Program
ID : N/A
Organisme : Philipp Foundation
ID : N/A
Organisme : apanese Foundation for Pediatric Research
ID : N/A
Organisme : New York Hideyo Noguchi Memorial Society
ID : N/A
Organisme : Funai Foundation for Information Technology
ID : N/A
Organisme : Honjo International Scholarship Foundation (HISF)
ID : N/A
Organisme : HHS | NIH | National Cancer Institute (NCI)
ID : F99CA274708
Organisme : Department of Health of the New South Wales Government of Australia
ID : N/A
Organisme : DHAC | National Health and Medical Research Council (NHMRC)
ID : 1113904
Organisme : DHAC | National Health and Medical Research Council (NHMRC)
ID : 1042925
Organisme : DHAC | National Health and Medical Research Council (NHMRC)
ID : 1176665
Organisme : HHS | NIH | NIAID | Division of Intramural Research (DIR, NIAID)
ID : N/A
Organisme : HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
ID : N/A
Organisme : Stavros Niarchos Foundation (SNF)
ID : N/A
Organisme : European Society for Immunodeficiencies (ESID)
ID : N/A
Déclaration de conflit d'intérêts
Competing interests statement:Tim Niehues was a co-author on publications with the following co-authors within the last 4 y: K.B., C.S.M., and S.G.T. (https://doi.org/10.1182/blood.2020006738) and K.B. (https://doi.org/10.1016/j.jaci.2019.11.051; https://doi.org/10.1002/eji.202048713). Andrew R. Gennery was a co-author with S.G.T. (https://doi.org/10.1016/j.jaci.2020.09.010; https://doi.org/10.1016/j.jaci.2022.09.002) within the last 4 y.